Literature DB >> 8938307

T1 and T2 alterations in the brains of patients with hepatic cirrhosis.

J Vymazal1, M Babis, R A Brooks, K Filip, M Dezortova, H Hrncarkova, M Hajek.   

Abstract

PURPOSE: To determine whether previously reported T1-weighted MR hyperintensities in the brains of patients with hepatic cirrhosis are accompanied by changes in T2.
METHODS: We measured T1 and T2 in the brains of 10 patients with chronic liver disease and 7 age-matched healthy volunteers, using classic spin-echo sequences with multiple saturation recovery times and multiple echoes.
RESULTS: Both T1 and T2 were shortened in the basal ganglia, cortex, and white matter of the patients, with the greatest shortening in the globus pallidus, where 1/T1 was increased by 0.76 s-1 or 74% and 1/T2 by 1.45 s-1 or 11%.
CONCLUSIONS: The T1 changes were accompanied by T2 changes of greater magnitude that were not as visible because T2 is normally much shorter than T1, especially in the globus pallidus.

Entities:  

Mesh:

Year:  1996        PMID: 8938307      PMCID: PMC8338387     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  13 in total

Review 1.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

2.  MR imaging of heat stroke: external capsule and thalamic T1 shortening and cerebellar injury.

Authors:  Carol T McLaughlin; Arthur G Kane; Andrew E Auber
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

3.  Measurement of Signal-to-Noise and Contrast-to-Noise in the fBIRN Multicenter Imaging Study.

Authors:  Vincent A Magnotta; Lee Friedman
Journal:  J Digit Imaging       Date:  2006-06       Impact factor: 4.056

Review 4.  Manganese accumulation in the brain: MR imaging.

Authors:  A Uchino; T Noguchi; K Nomiyama; Y Takase; T Nakazono; J Nojiri; S Kudo
Journal:  Neuroradiology       Date:  2007-07-12       Impact factor: 2.804

5.  Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome.

Authors:  A M McKinney; B D Lohman; B Sarikaya; E Uhlmann; J Spanbauer; T Singewald; J R Brace
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-06       Impact factor: 3.825

6.  MR brain imaging of fucosidosis type I.

Authors:  P Galluzzi; A Rufa; P Balestri; A Cerase; A Federico
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

7.  Chronic liver disease: relaxometry in the brain after liver transplantation.

Authors:  V Herynek; M Babis; P Trunecka; K Filip; J Vymazal; M Dezortová; M Hájek
Journal:  MAGMA       Date:  2001-03       Impact factor: 2.310

8.  Pattern approach to MR imaging in patients with end-stage hepatic failure: a proposal for a new disease entity "hepatic encephalopathy continuum".

Authors:  Ho Kyun Kim; Hui Joong Lee; Wonho Lee; Yong Sun Kim; Han Won Jang; Kyung Hwan Byun
Journal:  Neuroradiology       Date:  2008-05-14       Impact factor: 2.804

9.  Magnetic resonance T2-relaxometry and 2D L-correlated spectroscopy in patients with minimal hepatic encephalopathy.

Authors:  Aparna Singhal; Rajakumar Nagarajan; Rajesh Kumar; Amir Huda; Rakesh K Gupta; M Albert Thomas
Journal:  J Magn Reson Imaging       Date:  2009-11       Impact factor: 4.813

10.  Fucosidosis: MRI and MRS findings.

Authors:  Ali Yusuf Oner; Ali Cansu; Sergin Akpek; Ayse Serdaroglu
Journal:  Pediatr Radiol       Date:  2007-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.